nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Methotrexate—psoriatic arthritis	0.229	0.265	CbGbCtD
Raloxifene—CYP19A1—Betamethasone—psoriatic arthritis	0.228	0.264	CbGbCtD
Raloxifene—CYP19A1—Dexamethasone—psoriatic arthritis	0.133	0.153	CbGbCtD
Raloxifene—CYP2B6—Dexamethasone—psoriatic arthritis	0.0548	0.0632	CbGbCtD
Raloxifene—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0445	0.0514	CbGbCtD
Raloxifene—CYP2C8—Dexamethasone—psoriatic arthritis	0.0415	0.0479	CbGbCtD
Raloxifene—CYP3A4—Triamcinolone—psoriatic arthritis	0.0337	0.0389	CbGbCtD
Raloxifene—CYP3A4—Betamethasone—psoriatic arthritis	0.0289	0.0334	CbGbCtD
Raloxifene—CYP3A4—Prednisolone—psoriatic arthritis	0.0285	0.033	CbGbCtD
Raloxifene—CYP3A4—Prednisone—psoriatic arthritis	0.027	0.0311	CbGbCtD
Raloxifene—CYP3A4—Dexamethasone—psoriatic arthritis	0.0168	0.0194	CbGbCtD
Raloxifene—Retinal vein thrombosis—Methotrexate—psoriatic arthritis	0.00742	0.0555	CcSEcCtD
Raloxifene—Thromboembolic event—Methotrexate—psoriatic arthritis	0.00289	0.0216	CcSEcCtD
Raloxifene—Embolism venous—Prednisolone—psoriatic arthritis	0.00254	0.019	CcSEcCtD
Raloxifene—Embolism venous—Triamcinolone—psoriatic arthritis	0.00234	0.0175	CcSEcCtD
Raloxifene—Embolism venous—Methylprednisolone—psoriatic arthritis	0.00233	0.0174	CcSEcCtD
Raloxifene—Conjunctivitis—Auranofin—psoriatic arthritis	0.00219	0.0163	CcSEcCtD
Raloxifene—Embolism venous—Dexamethasone—psoriatic arthritis	0.00212	0.0158	CcSEcCtD
Raloxifene—Embolism venous—Betamethasone—psoriatic arthritis	0.00212	0.0158	CcSEcCtD
Raloxifene—Embolism—Prednisolone—psoriatic arthritis	0.002	0.0149	CcSEcCtD
Raloxifene—Embolism venous—Prednisone—psoriatic arthritis	0.00185	0.0138	CcSEcCtD
Raloxifene—Embolism—Triamcinolone—psoriatic arthritis	0.00184	0.0137	CcSEcCtD
Raloxifene—Embolism—Methylprednisolone—psoriatic arthritis	0.00183	0.0137	CcSEcCtD
Raloxifene—Flatulence—Auranofin—psoriatic arthritis	0.00173	0.0129	CcSEcCtD
Raloxifene—Embolism—Betamethasone—psoriatic arthritis	0.00167	0.0125	CcSEcCtD
Raloxifene—Embolism—Dexamethasone—psoriatic arthritis	0.00167	0.0125	CcSEcCtD
Raloxifene—Embolism—Prednisone—psoriatic arthritis	0.00145	0.0108	CcSEcCtD
Raloxifene—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0014	0.0105	CcSEcCtD
Raloxifene—Cough increased—Triamcinolone—psoriatic arthritis	0.00129	0.00963	CcSEcCtD
Raloxifene—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.00128	0.00957	CcSEcCtD
Raloxifene—Vaginal discharge—Methotrexate—psoriatic arthritis	0.00128	0.00957	CcSEcCtD
Raloxifene—Dyspepsia—Auranofin—psoriatic arthritis	0.00126	0.00944	CcSEcCtD
Raloxifene—Embolism—Methotrexate—psoriatic arthritis	0.00121	0.00907	CcSEcCtD
Raloxifene—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00117	0.00877	CcSEcCtD
Raloxifene—Abdominal pain—Auranofin—psoriatic arthritis	0.00113	0.00848	CcSEcCtD
Raloxifene—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.00107	0.008	CcSEcCtD
Raloxifene—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.000984	0.00736	CcSEcCtD
Raloxifene—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.000982	0.00734	CcSEcCtD
Raloxifene—Diarrhoea—Auranofin—psoriatic arthritis	0.000981	0.00734	CcSEcCtD
Raloxifene—Vomiting—Auranofin—psoriatic arthritis	0.000912	0.00682	CcSEcCtD
Raloxifene—Rash—Auranofin—psoriatic arthritis	0.000904	0.00676	CcSEcCtD
Raloxifene—Dermatitis—Auranofin—psoriatic arthritis	0.000904	0.00676	CcSEcCtD
Raloxifene—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.000893	0.00667	CcSEcCtD
Raloxifene—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.000893	0.00667	CcSEcCtD
Raloxifene—Nausea—Auranofin—psoriatic arthritis	0.000852	0.00637	CcSEcCtD
Raloxifene—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.000779	0.00582	CcSEcCtD
Raloxifene—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.000779	0.00582	CcSEcCtD
Raloxifene—Diabetes mellitus—Prednisone—psoriatic arthritis	0.000777	0.00581	CcSEcCtD
Raloxifene—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000772	0.00577	CcSEcCtD
Raloxifene—Migraine—Dexamethasone—psoriatic arthritis	0.000764	0.00571	CcSEcCtD
Raloxifene—Migraine—Betamethasone—psoriatic arthritis	0.000764	0.00571	CcSEcCtD
Raloxifene—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00076	0.00569	CcSEcCtD
Raloxifene—Cystitis—Methotrexate—psoriatic arthritis	0.000752	0.00562	CcSEcCtD
Raloxifene—Influenza—Triamcinolone—psoriatic arthritis	0.00074	0.00553	CcSEcCtD
Raloxifene—Vaginal infection—Methotrexate—psoriatic arthritis	0.000735	0.00549	CcSEcCtD
Raloxifene—Weight increased—Prednisolone—psoriatic arthritis	0.000732	0.00547	CcSEcCtD
Raloxifene—Bronchitis—Triamcinolone—psoriatic arthritis	0.000711	0.00532	CcSEcCtD
Raloxifene—Bladder pain—Methotrexate—psoriatic arthritis	0.000704	0.00526	CcSEcCtD
Raloxifene—Conjunctivitis—Prednisolone—psoriatic arthritis	0.000697	0.00521	CcSEcCtD
Raloxifene—Weight increased—Triamcinolone—psoriatic arthritis	0.000673	0.00503	CcSEcCtD
Raloxifene—Weight increased—Methylprednisolone—psoriatic arthritis	0.000672	0.00502	CcSEcCtD
Raloxifene—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.00065	0.00486	CcSEcCtD
Raloxifene—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.000641	0.00479	CcSEcCtD
Raloxifene—Sweating—Methylprednisolone—psoriatic arthritis	0.000631	0.00472	CcSEcCtD
Raloxifene—Weight increased—Betamethasone—psoriatic arthritis	0.000611	0.00457	CcSEcCtD
Raloxifene—Weight increased—Dexamethasone—psoriatic arthritis	0.000611	0.00457	CcSEcCtD
Raloxifene—Rhinitis—Triamcinolone—psoriatic arthritis	0.000594	0.00444	CcSEcCtD
Raloxifene—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000592	0.00443	CcSEcCtD
Raloxifene—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000588	0.00439	CcSEcCtD
Raloxifene—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000582	0.00435	CcSEcCtD
Raloxifene—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000582	0.00435	CcSEcCtD
Raloxifene—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00058	0.00434	CcSEcCtD
Raloxifene—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000577	0.00431	CcSEcCtD
Raloxifene—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000548	0.0041	CcSEcCtD
Raloxifene—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000536	0.00401	CcSEcCtD
Raloxifene—Weight increased—Prednisone—psoriatic arthritis	0.000532	0.00398	CcSEcCtD
Raloxifene—Depression—Prednisone—psoriatic arthritis	0.00052	0.00388	CcSEcCtD
Raloxifene—Breast disorder—Methotrexate—psoriatic arthritis	0.000511	0.00382	CcSEcCtD
Raloxifene—Vertigo—Prednisolone—psoriatic arthritis	0.000504	0.00376	CcSEcCtD
Raloxifene—Syncope—Prednisolone—psoriatic arthritis	0.000503	0.00376	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000493	0.00368	CcSEcCtD
Raloxifene—Angiopathy—Dexamethasone—psoriatic arthritis	0.000487	0.00364	CcSEcCtD
Raloxifene—Angiopathy—Betamethasone—psoriatic arthritis	0.000487	0.00364	CcSEcCtD
Raloxifene—Vertigo—Triamcinolone—psoriatic arthritis	0.000463	0.00346	CcSEcCtD
Raloxifene—Syncope—Triamcinolone—psoriatic arthritis	0.000462	0.00346	CcSEcCtD
Raloxifene—Vertigo—Methylprednisolone—psoriatic arthritis	0.000462	0.00345	CcSEcCtD
Raloxifene—Syncope—Methylprednisolone—psoriatic arthritis	0.000461	0.00345	CcSEcCtD
Raloxifene—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00046	0.00344	CcSEcCtD
Raloxifene—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000453	0.00339	CcSEcCtD
Raloxifene—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000452	0.00338	CcSEcCtD
Raloxifene—Shock—Prednisolone—psoriatic arthritis	0.00045	0.00336	CcSEcCtD
Raloxifene—Cough—Triamcinolone—psoriatic arthritis	0.00045	0.00336	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000442	0.00331	CcSEcCtD
Raloxifene—Myalgia—Triamcinolone—psoriatic arthritis	0.000439	0.00328	CcSEcCtD
Raloxifene—Pneumonia—Methotrexate—psoriatic arthritis	0.000438	0.00327	CcSEcCtD
Raloxifene—Myalgia—Methylprednisolone—psoriatic arthritis	0.000438	0.00327	CcSEcCtD
Raloxifene—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000438	0.00327	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000435	0.00325	CcSEcCtD
Raloxifene—Depression—Methotrexate—psoriatic arthritis	0.000434	0.00325	CcSEcCtD
Raloxifene—Flushing—Prednisone—psoriatic arthritis	0.000434	0.00325	CcSEcCtD
Raloxifene—Angiopathy—Prednisone—psoriatic arthritis	0.000424	0.00317	CcSEcCtD
Raloxifene—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000423	0.00316	CcSEcCtD
Raloxifene—Vertigo—Betamethasone—psoriatic arthritis	0.00042	0.00314	CcSEcCtD
Raloxifene—Vertigo—Dexamethasone—psoriatic arthritis	0.00042	0.00314	CcSEcCtD
Raloxifene—Syncope—Betamethasone—psoriatic arthritis	0.000419	0.00314	CcSEcCtD
Raloxifene—Syncope—Dexamethasone—psoriatic arthritis	0.000419	0.00314	CcSEcCtD
Raloxifene—Infection—Triamcinolone—psoriatic arthritis	0.000418	0.00312	CcSEcCtD
Raloxifene—Sweating—Methotrexate—psoriatic arthritis	0.000418	0.00312	CcSEcCtD
Raloxifene—Infection—Methylprednisolone—psoriatic arthritis	0.000417	0.00312	CcSEcCtD
Raloxifene—Shock—Triamcinolone—psoriatic arthritis	0.000414	0.00309	CcSEcCtD
Raloxifene—Insomnia—Prednisolone—psoriatic arthritis	0.000414	0.00309	CcSEcCtD
Raloxifene—Shock—Methylprednisolone—psoriatic arthritis	0.000413	0.00309	CcSEcCtD
Raloxifene—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000412	0.00308	CcSEcCtD
Raloxifene—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000411	0.00307	CcSEcCtD
Raloxifene—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000411	0.00307	CcSEcCtD
Raloxifene—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000408	0.00305	CcSEcCtD
Raloxifene—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000407	0.00304	CcSEcCtD
Raloxifene—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000406	0.00303	CcSEcCtD
Raloxifene—Myalgia—Dexamethasone—psoriatic arthritis	0.000398	0.00298	CcSEcCtD
Raloxifene—Myalgia—Betamethasone—psoriatic arthritis	0.000398	0.00298	CcSEcCtD
Raloxifene—Pain—Prednisolone—psoriatic arthritis	0.000391	0.00292	CcSEcCtD
Raloxifene—Pharyngitis—Methotrexate—psoriatic arthritis	0.000388	0.0029	CcSEcCtD
Raloxifene—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000386	0.00289	CcSEcCtD
Raloxifene—Urethral disorder—Methotrexate—psoriatic arthritis	0.000383	0.00287	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000383	0.00286	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000382	0.00286	CcSEcCtD
Raloxifene—Insomnia—Triamcinolone—psoriatic arthritis	0.00038	0.00284	CcSEcCtD
Raloxifene—Insomnia—Methylprednisolone—psoriatic arthritis	0.00038	0.00284	CcSEcCtD
Raloxifene—Infection—Betamethasone—psoriatic arthritis	0.000379	0.00283	CcSEcCtD
Raloxifene—Infection—Dexamethasone—psoriatic arthritis	0.000379	0.00283	CcSEcCtD
Raloxifene—Shock—Betamethasone—psoriatic arthritis	0.000375	0.00281	CcSEcCtD
Raloxifene—Shock—Dexamethasone—psoriatic arthritis	0.000375	0.00281	CcSEcCtD
Raloxifene—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000374	0.0028	CcSEcCtD
Raloxifene—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000374	0.0028	CcSEcCtD
Raloxifene—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000374	0.00279	CcSEcCtD
Raloxifene—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000374	0.00279	CcSEcCtD
Raloxifene—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00037	0.00277	CcSEcCtD
Raloxifene—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000369	0.00276	CcSEcCtD
Raloxifene—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000369	0.00276	CcSEcCtD
Raloxifene—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000369	0.00276	CcSEcCtD
Raloxifene—Vertigo—Prednisone—psoriatic arthritis	0.000366	0.00274	CcSEcCtD
Raloxifene—Syncope—Prednisone—psoriatic arthritis	0.000365	0.00273	CcSEcCtD
Raloxifene—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000363	0.00271	CcSEcCtD
Raloxifene—Pain—Triamcinolone—psoriatic arthritis	0.00036	0.00269	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisone—psoriatic arthritis	0.000358	0.00268	CcSEcCtD
Raloxifene—Angiopathy—Methotrexate—psoriatic arthritis	0.000355	0.00265	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000348	0.0026	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000348	0.0026	CcSEcCtD
Raloxifene—Arthralgia—Prednisone—psoriatic arthritis	0.000347	0.00259	CcSEcCtD
Raloxifene—Myalgia—Prednisone—psoriatic arthritis	0.000347	0.00259	CcSEcCtD
Raloxifene—Insomnia—Betamethasone—psoriatic arthritis	0.000345	0.00258	CcSEcCtD
Raloxifene—Insomnia—Dexamethasone—psoriatic arthritis	0.000345	0.00258	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000344	0.00257	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000343	0.00257	CcSEcCtD
Raloxifene—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000336	0.00251	CcSEcCtD
Raloxifene—Dyspepsia—Betamethasone—psoriatic arthritis	0.000336	0.00251	CcSEcCtD
Raloxifene—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000332	0.00249	CcSEcCtD
Raloxifene—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000332	0.00248	CcSEcCtD
Raloxifene—Infection—Prednisone—psoriatic arthritis	0.00033	0.00247	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000329	0.00246	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000329	0.00246	CcSEcCtD
Raloxifene—Shock—Prednisone—psoriatic arthritis	0.000327	0.00244	CcSEcCtD
Raloxifene—Pain—Betamethasone—psoriatic arthritis	0.000326	0.00244	CcSEcCtD
Raloxifene—Pain—Dexamethasone—psoriatic arthritis	0.000326	0.00244	CcSEcCtD
Raloxifene—Nervous system disorder—Prednisone—psoriatic arthritis	0.000326	0.00244	CcSEcCtD
Raloxifene—Skin disorder—Prednisone—psoriatic arthritis	0.000323	0.00241	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000321	0.0024	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000312	0.00233	CcSEcCtD
Raloxifene—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000312	0.00233	CcSEcCtD
Raloxifene—Vertigo—Methotrexate—psoriatic arthritis	0.000306	0.00229	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000303	0.00226	CcSEcCtD
Raloxifene—Dizziness—Prednisolone—psoriatic arthritis	0.000302	0.00226	CcSEcCtD
Raloxifene—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000302	0.00226	CcSEcCtD
Raloxifene—Abdominal pain—Betamethasone—psoriatic arthritis	0.000302	0.00226	CcSEcCtD
Raloxifene—Body temperature increased—Betamethasone—psoriatic arthritis	0.000302	0.00226	CcSEcCtD
Raloxifene—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000302	0.00226	CcSEcCtD
Raloxifene—Insomnia—Prednisone—psoriatic arthritis	0.000301	0.00225	CcSEcCtD
Raloxifene—Cough—Methotrexate—psoriatic arthritis	0.000297	0.00222	CcSEcCtD
Raloxifene—Dyspepsia—Prednisone—psoriatic arthritis	0.000293	0.00219	CcSEcCtD
Raloxifene—Arthralgia—Methotrexate—psoriatic arthritis	0.00029	0.00217	CcSEcCtD
Raloxifene—Myalgia—Methotrexate—psoriatic arthritis	0.00029	0.00217	CcSEcCtD
Raloxifene—Chest pain—Methotrexate—psoriatic arthritis	0.00029	0.00217	CcSEcCtD
Raloxifene—Rash—Prednisolone—psoriatic arthritis	0.000288	0.00216	CcSEcCtD
Raloxifene—Dermatitis—Prednisolone—psoriatic arthritis	0.000288	0.00215	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000288	0.00215	CcSEcCtD
Raloxifene—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000287	0.00215	CcSEcCtD
Raloxifene—Headache—Prednisolone—psoriatic arthritis	0.000287	0.00214	CcSEcCtD
Raloxifene—Dizziness—Triamcinolone—psoriatic arthritis	0.000278	0.00208	CcSEcCtD
Raloxifene—Dizziness—Methylprednisolone—psoriatic arthritis	0.000278	0.00207	CcSEcCtD
Raloxifene—Infection—Methotrexate—psoriatic arthritis	0.000276	0.00206	CcSEcCtD
Raloxifene—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000272	0.00204	CcSEcCtD
Raloxifene—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000272	0.00203	CcSEcCtD
Raloxifene—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000272	0.00203	CcSEcCtD
Raloxifene—Nausea—Prednisolone—psoriatic arthritis	0.000272	0.00203	CcSEcCtD
Raloxifene—Skin disorder—Methotrexate—psoriatic arthritis	0.00027	0.00202	CcSEcCtD
Raloxifene—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000269	0.00201	CcSEcCtD
Raloxifene—Vomiting—Triamcinolone—psoriatic arthritis	0.000267	0.002	CcSEcCtD
Raloxifene—Vomiting—Methylprednisolone—psoriatic arthritis	0.000267	0.00199	CcSEcCtD
Raloxifene—Rash—Triamcinolone—psoriatic arthritis	0.000265	0.00198	CcSEcCtD
Raloxifene—Dermatitis—Triamcinolone—psoriatic arthritis	0.000265	0.00198	CcSEcCtD
Raloxifene—Rash—Methylprednisolone—psoriatic arthritis	0.000265	0.00198	CcSEcCtD
Raloxifene—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000264	0.00198	CcSEcCtD
Raloxifene—Headache—Triamcinolone—psoriatic arthritis	0.000263	0.00197	CcSEcCtD
Raloxifene—Headache—Methylprednisolone—psoriatic arthritis	0.000263	0.00197	CcSEcCtD
Raloxifene—Body temperature increased—Prednisone—psoriatic arthritis	0.000263	0.00196	CcSEcCtD
Raloxifene—Abdominal pain—Prednisone—psoriatic arthritis	0.000263	0.00196	CcSEcCtD
Raloxifene—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000261	0.00195	CcSEcCtD
Raloxifene—Diarrhoea—Betamethasone—psoriatic arthritis	0.000261	0.00195	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000253	0.00189	CcSEcCtD
Raloxifene—Dizziness—Betamethasone—psoriatic arthritis	0.000252	0.00189	CcSEcCtD
Raloxifene—Dizziness—Dexamethasone—psoriatic arthritis	0.000252	0.00189	CcSEcCtD
Raloxifene—Insomnia—Methotrexate—psoriatic arthritis	0.000251	0.00188	CcSEcCtD
Raloxifene—Nausea—Triamcinolone—psoriatic arthritis	0.00025	0.00187	CcSEcCtD
Raloxifene—Nausea—Methylprednisolone—psoriatic arthritis	0.000249	0.00186	CcSEcCtD
Raloxifene—Dyspepsia—Methotrexate—psoriatic arthritis	0.000245	0.00183	CcSEcCtD
Raloxifene—Vomiting—Dexamethasone—psoriatic arthritis	0.000243	0.00181	CcSEcCtD
Raloxifene—Vomiting—Betamethasone—psoriatic arthritis	0.000243	0.00181	CcSEcCtD
Raloxifene—Rash—Dexamethasone—psoriatic arthritis	0.000241	0.0018	CcSEcCtD
Raloxifene—Rash—Betamethasone—psoriatic arthritis	0.000241	0.0018	CcSEcCtD
Raloxifene—Dermatitis—Betamethasone—psoriatic arthritis	0.00024	0.0018	CcSEcCtD
Raloxifene—Dermatitis—Dexamethasone—psoriatic arthritis	0.00024	0.0018	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00024	0.00179	CcSEcCtD
Raloxifene—Headache—Betamethasone—psoriatic arthritis	0.000239	0.00179	CcSEcCtD
Raloxifene—Headache—Dexamethasone—psoriatic arthritis	0.000239	0.00179	CcSEcCtD
Raloxifene—Pain—Methotrexate—psoriatic arthritis	0.000238	0.00178	CcSEcCtD
Raloxifene—Diarrhoea—Prednisone—psoriatic arthritis	0.000227	0.0017	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000227	0.0017	CcSEcCtD
Raloxifene—Nausea—Dexamethasone—psoriatic arthritis	0.000227	0.00169	CcSEcCtD
Raloxifene—Nausea—Betamethasone—psoriatic arthritis	0.000227	0.00169	CcSEcCtD
Raloxifene—Dizziness—Prednisone—psoriatic arthritis	0.00022	0.00164	CcSEcCtD
Raloxifene—Body temperature increased—Methotrexate—psoriatic arthritis	0.00022	0.00164	CcSEcCtD
Raloxifene—Abdominal pain—Methotrexate—psoriatic arthritis	0.00022	0.00164	CcSEcCtD
Raloxifene—Vomiting—Prednisone—psoriatic arthritis	0.000211	0.00158	CcSEcCtD
Raloxifene—Rash—Prednisone—psoriatic arthritis	0.00021	0.00157	CcSEcCtD
Raloxifene—Dermatitis—Prednisone—psoriatic arthritis	0.000209	0.00157	CcSEcCtD
Raloxifene—Headache—Prednisone—psoriatic arthritis	0.000208	0.00156	CcSEcCtD
Raloxifene—Nausea—Prednisone—psoriatic arthritis	0.000197	0.00148	CcSEcCtD
Raloxifene—Diarrhoea—Methotrexate—psoriatic arthritis	0.00019	0.00142	CcSEcCtD
Raloxifene—Dizziness—Methotrexate—psoriatic arthritis	0.000184	0.00137	CcSEcCtD
Raloxifene—Vomiting—Methotrexate—psoriatic arthritis	0.000177	0.00132	CcSEcCtD
Raloxifene—Rash—Methotrexate—psoriatic arthritis	0.000175	0.00131	CcSEcCtD
Raloxifene—Dermatitis—Methotrexate—psoriatic arthritis	0.000175	0.00131	CcSEcCtD
Raloxifene—Headache—Methotrexate—psoriatic arthritis	0.000174	0.0013	CcSEcCtD
Raloxifene—Nausea—Methotrexate—psoriatic arthritis	0.000165	0.00123	CcSEcCtD
